APA (7th ed.) Citation

K, D., J, H., Q, W., J, X., X, Y., S, Y., . . . C, G. (2026). A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects. Frontiers in pharmacology, 17, 1821901. https://doi.org/10.3389/fphar.2026.1821901

Chicago Style (17th ed.) Citation

K, Deng, et al. "A Randomized Controlled Phase Ia Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of Tofacitinib Tartrate Cream (HZ-J001) in Healthy Chinese Subjects." Frontiers in Pharmacology 17 (2026): 1821901. https://doi.org/10.3389/fphar.2026.1821901.

MLA (9th ed.) Citation

K, Deng, et al. "A Randomized Controlled Phase Ia Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of Tofacitinib Tartrate Cream (HZ-J001) in Healthy Chinese Subjects." Frontiers in Pharmacology, vol. 17, 2026, p. 1821901, https://doi.org/10.3389/fphar.2026.1821901.